osimertinib
astrazeneca
['sclc', 'nsclc', 'adaura', 'aura ,(-laura)']
dava team is kicking off #asco23 with a multidisciplinary case-based panel following an egfr mut nsclc patient from early stage to metastatic disease featuring giulia veronesi and . excited for updated adaura os data on sunday! 
DAVA Oncology is a strategic consulting company that offers numerous products and services customized to fit biopharmaceutical drug development needs.